Melatonin stimulates glucagon secretion in vitro and in vivo (Q39606472)

13 September 2017

Melatonin stimulates glucagon secretion in vitro and in vivo (English)

1 reference

13 September 2017

0 references

1 reference

4

1 reference

13 September 2017

Ina Bähr

1

1 reference

PubMed ID

21244480

13 September 2017

Eckhard Mühlbauer

series ordinal

2

1 reference

PubMed ID

21244480

13 September 2017

Helena Schucht

series ordinal

3

1 reference

13 September 2017

18 January 2011

1 reference

Journal of Pineal Research

13 September 2017

1 reference

13 September 2017

50

1 reference

13 September 2017

336-344

1 reference

13 September 2017

3

1 reference

A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects

13 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Sleep duration as a risk factor for the development of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Association of sleep time with diabetes mellitus and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

MTNR1B G24E variant associates With BMI and fasting plasma glucose in the general population in studies of 22,142 Europeans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Variants in MTNR1B influence fasting glucose levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Melatonin and type 2 diabetes - a possible link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Identification and functional characterization of melatonin Mel 1a receptors in pancreatic beta cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Function and expression of melatonin receptors on human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Parallel signaling pathways of melatonin in the pancreatic beta-cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Transcripts of calcium/calmodulin-dependent kinases are changed after forskolin- or IBMX-induced insulin secretion due to melatonin treatment of rat insulinoma beta-cells (INS-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Receptor (MT(1)) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Melatonin inhibits insulin secretion and decreases PKA levels without interfering with glucose metabolism in rat pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Modulation of the cGMP signaling pathway by melatonin in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Long-term enteral administration of melatonin reduces plasma insulin and increases expression of pineal insulin receptors in both Wistar and type 2-diabetic Goto-Kakizaki rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Daily rhythm of glucose-induced insulin secretion by isolated islets from intact and pinealectomized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Long-term melatonin administration reduces hyperinsulinemia and improves the altered fatty-acid compositions in type 2 diabetic rats via the restoration of Delta-5 desaturase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Increased melatonin synthesis in pineal glands of rats in streptozotocin induced type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Role of SCN in daily rhythms of plasma glucose, FFA, insulin and glucagon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

The daily rhythm in plasma glucagon concentrations in the rat is modulated by the biological clock and by feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Effects of pinealectomy on glucagon responsiveness to hypoglycaemia induced by insulin injections in fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Sleep loss alters basal metabolic hormone secretion and modulates the dynamic counterregulatory response to hypoglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Mild sleep restriction acutely reduces plasma glucagon levels in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Targeted disruption of the mouse Mel(1b) melatonin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Glucagon stimulates exocytosis in mouse and rat pancreatic alpha-cells by binding to glucagon receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic alpha-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Melatonin stimulates inositol-1,4,5-trisphosphate and Ca2+ release from INS1 insulinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Glycemic control in mice with targeted disruption of the glucagon receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Insulin inhibits glucagon secretion by the activation of PI3-kinase in In-R1-G9 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Intra-islet insulin permits glucose to directly suppress pancreatic A cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Relationship of glucagon suppression by insulin and somatostatin to the ambient glucose concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Stimulation of glucagon release by addition of anti-stomatostatin serum to islets of Langerhans in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Insulin responsiveness of the glucagon gene conferred by interactions between proximal promoter and more distal enhancer-like elements involving the paired-domain transcription factor Pax6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Repression of glucagon gene transcription by peroxisome proliferator-activated receptor gamma through inhibition of Pax6 transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Diurnal variations in the activities of the glycogen metabolizing enzymes in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Entrainment of the circadian clock in the liver by feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

Modulation of blood glucose by melatonin: a direct action on melatonin receptors in mouse hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

In vivo and in vitro regulation of hepatic glucagon receptor mRNA concentration by glucose metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00848.X

10.1111/J.1600-079X.2010.00848.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

21244480